# Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis

> **NCT03037788** · PHASE1 · COMPLETED · sponsor: **Dr. August Wolff GmbH & Co. KG Arzneimittel** · enrollment: 30 (actual)

## Conditions studied

- Primary Axillary Hyperhidrosis

## Interventions

- **DRUG:** WO3979
- **DRUG:** WO3970
- **DRUG:** WO3992
- **DRUG:** Placebo (WO3988)

## Key facts

- **NCT ID:** NCT03037788
- **Lead sponsor:** Dr. August Wolff GmbH & Co. KG Arzneimittel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-06
- **Final completion:** 2017-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03037788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03037788, "Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03037788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*